Financial statements Cardiopace
Balance sheet data of CARDIOPACE
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 3 381 520,25 | 4 595 588,18 | 4 432 263,94 | 5 286 502,77 | 6 025 844,84 | 6 670 906,27 |
| A. Fixed assets | 1 086 452,70 | 2 756 121,38 | 2 471 349,60 | 3 435 706,68 | 4 688 906,68 | 5 331 906,68 |
| B. Current assets | 2 295 067,55 | 1 839 466,80 | 1 960 914,34 | 1 850 796,09 | 1 336 938,16 | 1 338 999,59 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 3 381 520,25 | 4 595 588,18 | 4 432 263,94 | 5 286 502,77 | 6 025 844,84 | 6 670 906,27 |
| A. Equity | 2 814 682,63 | 3 312 174,81 | 3 253 146,71 | 4 405 037,36 | 5 609 633,43 | 6 408 049,20 |
| B. Liabilities and provisions for liabilities | 566 837,62 | 1 283 413,37 | 1 179 117,23 | 881 465,41 | 416 211,41 | 262 857,07 |
| I. Long-term liabilities | 0,00 | 305 570,00 | 241 360,00 | 120 275,00 | 0,00 | - |
| II. Short-term liabilities | 566 837,62 | 977 843,37 | 937 757,23 | 761 190,41 | 416 211,41 | 262 857,07 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.